Pancreatic Intraepithelial Neoplasia

Surgical Pathology Clinics

Volumn 4, Issue 2, 2011, Pages 523-535

  Cornish, Toby C ^a   Hruban, Ralph H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Acinar ductal metaplasia; Carcinogenesis; Lobulocentric atrophy; Pancreas; Pancreatic cancer precursors; Pancreatic ductal adenocarcinoma; Pancreatic intraepithelial neoplasia; PanIN

Indexed keywords

CANCER INVASION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; IMMUNOPHENOTYPING; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PANCREATIC INTRAEPITHELIAL NEOPLASIA; PRIORITY JOURNAL; REVIEW;

EID: 79957643916     PISSN: 18759181     EISSN: 18759157     Source Type: Journal    
DOI: 10.1016/j.path.2011.03.005     Document Type: Review

References (39)

1. Surveillance epidemiology and end results: SEER stat facts sheets, pancreatic cancer Available at:, Accessed July 1, 2009. http://seer.cancer.gov/statfacts/html/pancreas.html.
2. Klimstra D.S., Longnecker D.S. K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 1994, 145(6):1547-1550.
3. Hruban R.H., Takaori K., Klimstra D.S., et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004, 28(8):977-987.
4. Hruban R.H., Adsay N.V., Albores-Saavedra J., et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001, 25(5):579-586.
5. Andea A., Sarkar F., Adsay V.N. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003, 16(10):996-1006.
6. Moskaluk C.A., Hruban R.H., Kern S.E. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997, 57(11):2140-2143.
7. Kozuka S., Sassa R., Taki T., et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979, 43(4):1418-1428.
8. Pour P.M., Sayed S., Sayed G. Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases. Am J Clin Pathol 1982, 77(2):137-152.
9. Terhune P.G., Phifer D.M., Tosteson T.D., et al. K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev 1998, 7(6):515-521.
10. Shi C., Klein A.P., Goggins M., et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin Cancer Res 2009, 15(24):7737-7743.
11. Rebours V., Levy P., Mosnier J.F., et al. Pathology analysis reveals that dysplastic pancreatic ductal lesions are frequent in patients with hereditary pancreatitis. Clin Gastroenterol Hepatol 2010, 8(2):206-212.
12. Shi C., Hruban R.H., Klein A.P. Familial pancreatic cancer. Arch Pathol Lab Med 2009, 133(3):365-374.
13. Albores-Saavedra J., Wu J., Crook T., et al. Intestinal and oncocytic variants of pancreatic intraepithelial neoplasia. A morphological and immunohistochemical study. Ann Diagn Pathol 2005, 9(2):69-76.
14. Albores-Saavedra J., Weimersheimer-Sandoval M., Chable-Montero F., et al. The foamy variant of pancreatic intraepithelial neoplasia. Ann Diagn Pathol 2008, 12(4):252-259.
15. Detlefsen S., Sipos B., Feyerabend B., et al. Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch 2005, 447(5):800-805.
16. Brune K., Abe T., Canto M., et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 2006, 30(9):1067-1076.
17. Meckler K.A., Brentnall T.A., Haggitt R.C., et al. Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma. Am J Surg Pathol 2001, 25(8):1047-1053.
18. Schmid R.M., Kloppel G., Adler G., et al. Acinar-ductal-carcinoma sequence in transforming growth factor-alpha transgenic mice. Ann N Y Acad Sci 1999, 880:219-230.
19. Bockman D.E., Black O., Mills L.R., et al. Origin of tubular complexes developing during induction of pancreatic adenocarcinoma by 7,12-dimethylbenz(a)anthracene. Am J Pathol 1978, 90(3):645-658.
20. Brembeck F.H., Schreiber F.S., Deramaudt T.B., et al. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res 2003, 63(9):2005-2009.
21. De La O.J.P., Emerson L.L., Goodman J.L., et al. Notch and kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A 2008, 105(48):18907-18912.
22. Grippo P.J., Nowlin P.S., Demeure M.J., et al. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant kras in transgenic mice. Cancer Res 2003, 63(9):2016-2019.
23. Shi C., Hong S.M., Lim P., et al. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin. Mol Cancer Res 2009, 7(2):230-236.
24. Horinouchi M., Nagata K., Nakamura A., et al. Expression of different glycoforms of membrane mucin (MUC1) and secretory mucin (MUC2, MUC5AC and MUC6) in pancreatic neoplasms. Acta Histochem Cytochem 2003, 36(5):443-453.
25. Adsay N.V., Merati K., Andea A., et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002, 15(10):1087-1095.
26. Nagata K., Horinouchi M., Saitou M., et al. Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg 2007, 14(3):243-254.
27. van Heek N.T., Meeker A.K., Kern S.E., et al. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002, 161(5):1541-1547.
28. Heinmoller E., Dietmaier W., Zirngibl H., et al. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol 2000, 157(1):83-92.
29. Lohr M., Kloppel G., Maisonneuve P., et al. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia 2005, 7(1):17-23.
30. Boschman C.R., Stryker S., Reddy J.K., et al. Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. Am J Pathol 1994, 145(6):1291-1295.
31. DiGiuseppe J.A., Hruban R.H., Offerhaus G.J., et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994, 144(5):889-895.
32. Wilentz R.E., Iacobuzio-Donahue C.A., Argani P., et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 2000, 60(7):2002-2006.
33. Koorstra J.B., Feldmann G., Habbe N., et al. Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs). Langenbecks Arch Surg 2008, 393(4):561-570.
34. Ryu J.K., Hong S.M., Karikari C.A., et al. Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology 2010, 10(1):66-73.
35. du Rieu M.C., Torrisani J., Selves J., et al. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. Clin Chem 2010, 56(4):603-612.
36. Sharma S., Green K.B. The pancreatic duct and its arteriovenous relationship: an underutilized aid in the diagnosis and distinction of pancreatic adenocarcinoma from pancreatic intraepithelial neoplasia. A study of 126 pancreatectomy specimens. Am J Surg Pathol 2004, 28(5):613-620.
37. Canto M.I., Goggins M., Hruban R.H., et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006, 4(6):766-781.
38. Brat D.J., Lillemoe K.D., Yeo C.J., et al. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 1998, 22(2):163-169.
39. Brockie E., Anand A., Albores-Saavedra J. Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma. Ann Diagn Pathol 1998, 2(5):286-292.